Indofarma Bonds, 11.5% 20mar2018, IDR (INAF02AXMF, IDH0000240A7)
Domestic bonds
Domestic bonds
Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market
Get accessBond parameters,
prospectuses
Analyze the data in the most efficient way
Current & historical quotes from 400+ stock exchanges & OTC market
Credit ratings, financial reports
Explore the most comprehensive database
1 000 000
bonds
80 234
stocks
167 970
ETF & Funds
70 000
indices
Track your portfolio in the most efficient way
full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.
Register|
As one of leading pharmaceutical companies in the Indonesia, PT. Indofarma (Persero), Tbk. has been serving the society for almost nine decades by providing quality pharmaceutical products. The root of the pharmaceutical company acknowledge as one ...
As one of leading pharmaceutical companies in the Indonesia, PT. Indofarma (Persero), Tbk. has been serving the society for almost nine decades by providing quality pharmaceutical products. The root of the pharmaceutical company acknowledge as one of pillars supporting national health system was Pabrik Obat Manggarai that was established in 1918 by the Dutch colonial administration.
In 2000, PT. Indofarma expanded downstrem into distribution and trading of pharmaceutical products and medical devices which name PT. Indofarma Global Medika. This allowed Indofarma to focus to its core business both in manufacturing and marketing of pharmaceutical products.
At present, Indofarma produces 229 items of pharmaceutical product, among them 53 are actively distributed in the market. Among the company's portofolio, 66 items are own brand products. Indofama produces generic products, over the counter products and traditional (herbal) products, and even food suplements.
To streghten its business structure, Indofarma strives to forge strategic alliances with international partners possesing needed branded products and/or technologies, both through the Holding and subsidiary company.
|
|
|
|
|
|
|
|
|
Explore the most comprehensive database
1 000 000
bonds
80 234
stocks
167 970
ETF & Funds
70 000
indices
Track your portfolio in the most efficient way
full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.
Register